Latest news
- Williams Rowland Acquisition Corp. Announces Closing of $200 Million Initial Public Offering
03:18 - GlobeNewswire - Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
02:40 - GlobeNewswire - iSIGN Media Announces a Proposed Private Placement of up to $1.2 million
02:30 - GlobeNewswire - Emergency state likely in four more Japan regions - minister
02:29 - TeleTrader - Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Kanzhun Limited Investors in Securities Fraud Class Action Lawsuit
02:10 - GlobeNewswire
Real-time